Seven years of safety and efficacy of the recombinant human growth hormone Omnitrope in the treatment of growth hormone deficient children: results of a phase III study.

Tomasz Romer,Paul Saenger,Ferenc Péter,M. Walczak,Y. Le Bouc,J. Khan-Boluki,A. Berghout

Seven years of safety and efficacy of the recombinant human growth hormone Omnitrope in the treatment of growth hormone deficient children: results of a phase III study.

2009

Tomasz Romer
Paul Saenger
Ferenc Péter
M. Walczak
Y. Le Bouc
J. Khan-Boluki
A. Berghout

Aim: This phase III clinical study in growth hormone deficiency (GHD) children with growth retardation was designed to compare efficacy and safety of Omnitrope® with Genotropin® and

Keywords:

Biosimilar
Internal medicine
Hormone
Endocrinology
Diabetes mellitus
Growth hormone treatment
Growth hormone deficiency
Medicine
growth hormone
Clinical trial
human growth hormone
Recombinant DNA

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations